2020, Number 2
Epidemiological clinical characteristics in patients with type I cardiorenal syndrome
Language: Spanish
References: 21
Page: 1-14
PDF size: 439.67 Kb.
ABSTRACT
Introduction: cardiorenal syndrome is of recent knowledge worldwide and requires adequate medical action from the early stages. In a classification with five typologies, type I is the most frequent.Objective: to describe the epidemiological clinical characteristics in patients with type I cardiorenal syndrome.
Methods: a cross-sectional descriptive observational study was carried out on the universe of 56 who were admitted to the cardiology ward of the Ciego de Ávila hospital between: April/2016-March/2018. A blood sample was taken to determine the parameters under study and a telecardiogram, electrocardiogram and echocardiogram was carried out. The information was obtained from the medical records. Ethical principles were met.
Results: predominance of the male sex (55,36 %), the age group 60 years and over (39,29 %), arterial hypertension as a risk factor and finding on physical examination (62.50 %), and decompensated chronic heart failure (51,79 %) as a type of acute heart failure. Left ventricular hypertrophy (51,79 %) was the main electrocardiographic change. The cardiothoracic index was normal in more than half (58,93 %) in the telecardiogram and diastolic dysfunction predominated (58,93 %) in the echocardiogram.
Conclusions: from the epidemiological point of view, it prevailed in men aged 60 years and over, and arterial hypertension was the most frequent risk factor. From the clinical point of view, decompensated chronic heart failure such as acute heart failure, arterial hypertension as a finding on cardiovascular physical examination, hypertrophy of the left ventricle as an electrocardiographic alteration and diastolic dysfunction as an echocardiographic one.
REFERENCES
Preza PM, Hurtado A, Armas V, Cárcamo CP. Síndrome cardiorenal tipo 1 en la unidad de cuidados intensivos coronarios del Hospital Nacional Arzobispo Loayza. Arch. Cardiol. Méx. [Internet]. 2015 [citado 12 Abr 2016];85(3):[aprox. 8 p.]. Disponible en: http://www.scielo.org.mx/scielo.php?pid=S1405-99402015000300002&script=sci_arttext
Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Bruse-Ferguson T, Flegal K, et al. Heart Disease and Stroke Statistics 2009 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. [Internet]. 2009 [citado 12 Abr 2016];119(3):e1-e161. Disponible en: https://www.ahajournals.org/action/deliverPdfSupplementaryAttachmentSecure?doi=10.1161%2FCIRCULATIONAHA.108.191261&uuid=uuid%3Aa559e2ea-13df-4bf0-b33b-32405068471e
Ministerio de Salud Pública (Cuba). Anuario Estadístico de Salud 2018 [Internet]. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2019 [citado 23 Jun 2019]. Disponible en: http://files.sld.cu/bvscuba/files/2019/04/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2018-ed-2019-compressed.pdf
Bodian M, Thiaw A, Sarr SA, Babaka K, Aw F, Ngaïde AA, et al. Syndromecardio-rénal: aspectsépidémiologiques, à propos de 36 cas dans un service de cardiologie de Dakar. Pan Afr Med J [Internet]. Sep 2017 [citado 23 May 2018];28(58):[aprox. 11 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718758/pdf/PAMJ-28-58.pdf
Kazory A, Elkayam U. Cardiorenal interactions in acute decompensated heart failure: contemporary concepts facing emerging controversies. J Card Fail [Internet]. 2014 [citado 15 Mar 2016];20(12):1004-11. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S1071916414012007.pdf?locale=es_ES&searchIndex=
Asociación Médica Mundial. Declaración de Helsinki de la AMM. Principios éticos para las investigaciones médicas en seres humanos. Ratificada en la 64ª Asamblea General, Fortaleza, Brasil, octubre 2013. Helsinki: 18ª Asamblea Mundial; 1964 [citado 30 Ene 2016]. Disponible en: http://www.anmat.gov.ar/comunicados/HELSINSKI_2013.pdf
Casado-Cerrada J, Pérez-Calvo JI. Daño orgánico y síndrome cardiorenal en la insuficiencia cardiaca aguda. Med Clin Barc [Internet]. Mar 2014 [citado 24 May 2018];142(Suppl.1):26-31. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S002577531470079X.pdf?locale=es_ES&searchIndex=
Dávila-Mora S, Zea-Dávila D, Nani-Silva E, Tinoco-Mesquita E, Andrade-Martins WA, Villacorta-Junior H. Síndrome cardio-renal tipo 1: Mecanismos fisiopatológicos y papel de los nuevos biomarcadores. Insuf Card [Internet]. Ene 2016 [citado 24 May 2018];11(1):55-62. Disponible en: http://www.insuficienciacardiaca.org/pdf/v11n1_16/31Sindrome-DavilaMora-Espa.pdf
Haase M, Müller C, Damman K, Murray PT, Kellum JA, Ronco C, et al. Pathogenesis of Cardiorenal Syndrome Type 1 in Acute Decompensated Heart Failure: Workgroup Statements from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol [Internet]. 2013[citado 24 May 2018];182:99-116. Disponible en: https://www.karger.com/Article/Pdf/349969
De Assis-Costa F, Romero-Rivera I, Castro-de Vasconcelos ML, Falcão-Pedrosa Costa A, Dos Santos-Póvoa RM, Nogueira-Bombig MT, et al. El electrocardiograma en el diagnóstico de la hipertrofia ventricular de pacientes con enfermedad renal crónica. Arq Bras Cardiol [Internet]. Oct 2009 [citado 24 Mar 2017];93(4):373-9. Disponible en: https://www.scielo.br/pdf/abc/v93n4/es_11.pdf
Álvarez-González Y, Bohorquez-Rodríguez R, Vega-Pedraza D, Noa-Fernández L. Alteraciones cardiovasculares de pacientes en un programa de diálisis peritoneal domiciliaria. Instituto de Nefrología, Cuba. Rev Cubana Cardiol Cir Cardiovasc [Internet]. 2017 [citado 6 Abr 2018];23(4):479-88. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/702/html_100
Mavrakanas T, Khattak A, Singh K, Charytan D. Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography. Clin J Am Soc Nephrol [Internet]. 2017 [citado 24 May 2018];12(10):1624-33. Disponible en: https://cjasn.asnjournals.org/content/clinjasn/12/10/1624.full.pdf